TYPE 1 DIABETES: IMPACT OF SGLT-2 INHIBITORS ON GLYCEMIC CONTROL

被引:0
|
作者
Lavrador, M. [1 ]
Araujo, B. [1 ]
Araujo, C. [1 ]
Melo, M. [1 ]
Baptista, C. [1 ]
Barros, L. [1 ]
Paiva, I. [1 ]
机构
[1] Ctr Hosp Univ Coimbra, Endocrinol, Coimbra, Portugal
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
EP241 / #5
引用
收藏
页码:A181 / A181
页数:1
相关论文
共 50 条
  • [1] The evolution of type 2 diabetes management: glycemic control and beyond with SGLT-2 inhibitors and GLP-1 receptor agonists
    Serowik, Thomas C.
    Pantalone, Kevin M.
    JOURNAL OF OSTEOPATHIC MEDICINE, 2024, 124 (03): : 127 - 135
  • [2] The nephrological perspective on SGLT-2 inhibitors in type 1 diabetes
    Gillard, Pieter
    Schnell, Oliver
    Groop, Per-Henrik
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 170
  • [3] Use of SGLT-2 Inhibitors in Patients With Type 1 Diabetes Mellitus
    El Hage, Lea
    Kashyap, Sangeeta R.
    Rao, Pratibha
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2019, 10
  • [4] SGLT-2 inhibitors as adjunctive to insulin therapy in type 1 diabetes
    Maj-Podsiadlo, Anna
    Cichocka, Edyta
    Gumprecht, Janusz
    CLINICAL DIABETOLOGY, 2020, 9 (03): : 189 - 192
  • [5] SGLT-2 Inhibitors: Is There a Role in Type 1 Diabetes Mellitus Management?
    Ahmed-Sarwar, Nabila
    Nagel, Angela K.
    Leistman, Samantha
    Heacock, Kevin
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (09) : 791 - 796
  • [6] The role of SGLT-2 inhibitors in managing type 2 diabetes
    Tsushima, Yumiko
    Lansang, M. Cecilia
    Makin, Vinni
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2021, 88 (01) : 47 - 58
  • [7] SGLT-2 inhibitors for people with type 2 diabetes Reply
    Zelniker, Thomas A.
    Wiviott, Stephen D.
    Raz, Itamar
    Sabatine, Marc S.
    LANCET, 2019, 394 (10198): : 560 - 561
  • [8] Effect of the SGLT-1 and SGLT-2 Inhibitors Sotagliflozine on the Treatment of Type 1 Diabetes mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2019, 15 (06): : 585 - 586
  • [9] SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the Literature
    Patoulias, Dimitrios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Athyros, Vasilios
    Doumas, Michael
    CURRENT CLINICAL PHARMACOLOGY, 2018, 13 (04): : 261 - 272
  • [10] SGLT-2 inhibitors and GLP-1 receptor agonists for Type 2 diabetes
    Davila, Esteban
    Mccormack, James
    ACADEMIC EMERGENCY MEDICINE, 2024, 31 (04) : 408 - 411